Ivan Foeldvari

Featured in: Favicon

bmj.com (+1) Favicon

springer.com Favicon

biomedcentral.com Favicon

healio.com Favicon

jrheum.org Favicon

onlinelibrary.wiley.com Favicon

link.springer.com Favicon

arthritis-research.biomedcentral.com

Articles

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐label, Phase 1 Trial

Nov 15, 2024 | acrjournals.onlinelibrary.wiley.com | Hermine I Brunner |Anna Shmagel |Gerd Horneff |Ivan Foeldvari

Supporting Information Filename Description acr25465-sup-0001-Disclosureform.pdfPDF document, 1.7 MB Disclosure Form acr25465-sup-0002-Supinfo.pdfPDF document, 290.8 KB Appendix S1: Supporting Information
Proposed response parameters for 12 months drug trial in Juvenile Systemic Sclerosis. Results of the Hamburg International Consensus Meetings

Jun 19, 2023 | onlinelibrary.wiley.com | Ivan Foeldvari |Adolescent Rheumatology |Kathryn S. Torok |Jens Klotsche

Original Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/acr.25171. Abstract Objectives Juvenile systemic sclerosis (jSSc) is an orphan disease, associated with high morbidity and mortality.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →